Ischemic Vascular Disease (IVD): Blood Pressure Management (NQF 0073)

EMeasure Name Ischemic Vascular Disease (IVD): Blood Pressure Management EMeasure Id 59726ED8-7CC7-48D3-BD2C-2BDC3371FBA6
Version number 1 Set Id 3E5BDF4E-F5AF-4743-90A1-DB8769347EB7
Available Date No information Measurement Period January 1, 20xx through December 31, 20xx
Measure Steward National Committee for Quality Assurance
Endorsed by National Quality Forum
Description The percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1st to November 1st of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and whose most recent blood pressure is in control (<140/90 mmHg).
Copyright
© National Committee for Quality Assurance. All Rights Reserved
Measure scoring Proportion
Measure type Process
Stratification
None
Risk Adjustment
None
Data Aggregation
Rationale
This measure evaluates the percentage of patients in a specific age demographic who had a diagnosis of IVD and demonstrated adequate blood pressure management. IVD and related conditions had an estimated cost burden of $393.5 billion in 2005 (AHA 2005). Hypertension is a risk factor for IVD and cerebrovascular disease (CVD). Fifty million or more Americans have high blood pressure that warrants treatment, according to the NHANES survey (JNC-7, 2003). Additionally, high blood pressure and its complications cost the U.S. economy more than $100 billion each year (NHLBI, 2004). The USPSTF recommends that clinicians screen adults 18 and older for high blood pressure (2007). Better control of blood pressure has been shown to result in a significant reduction of the probability of undesirable and costly outcomes. This measure facilitates the long-term management of blood pressure levels for patients with IVD.
Clinical Recommendation Statement
JNC-7: Treating SBP and DBP to targets that are <140/90 mmHg is associated with a decrease in CVD complications.
Improvement notation
Higher score indicates better quality
Measurement duration
24 month(s)
Reference
U.S. Preventive Services Task Force. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2007 Dec 4;147(11):783-6.
Reference
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 
The Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure
NIH Publication  No. 035233 December 2003.
Definition
Guidance

Table of Contents


Population criteria

Data criteria (QDS Data Elements)

Summary Calculation

Calculation is generic to all measures:



Measure set CLINICAL QUALITY MEASURE SET 2011-2012